CHICAGO - Gadopiclenol is emerging as an alternative gadolinium-based MRI contrast agent. To learn more about its potential, we spoke with Dr. Christiane Kuhl from the University Hospital Aachen in Germany at RSNA 2022.
Video from RSNA 2022: Gadopiclenol emerges as gadolinium-based contrast agent
Nov 30, 2022
Latest in Molecular Imaging
PET/MRI reveals sex differences in patients with autism
April 18, 2024
PET tracer for gliomas under expedited review
April 17, 2024